Related Experiment Video
Updated: Apr 18, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Dysbiotic bacteria translocate in progressive SIV infection
Z Klase1, A Ortiz2, C Deleage3
11] Program in Barrier Immunity and Repair, Immunopathogenesis Section, LMM, NIAID NIH, Bethesda, Maryland, USA [2] Present address: Department of Biological Sciences, University of the Sciences, Philadelphia, Pennsylvania, USA.
Human immunodeficiency virus (HIV) infection leads to gut barrier damage and bacterial translocation, primarily of Proteobacteria. Altering the gut microbiome may benefit HIV patients on antiretroviral therapy.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Gut CD4(+) T cell infection during HIV/SIV leads to cell loss and epithelial barrier damage.
- Microbial product translocation from the gut lumen activates the immune system, accelerating disease.
- Bacterial identity in microbial translocation during SIV infection remains largely unknown.
Purpose of the Study:
- To identify translocating bacteria in SIV-infected macaques.
- To analyze gut microbiome changes in healthy and SIV-infected macaques.
- To investigate the impact of antiretroviral therapy on the gut microbiome.
Main Methods:
- Examined bacterial communities in the GI tract and systemic tissues of healthy and SIV-infected Asian macaques.
- Analyzed bacterial DNA from tissues to identify translocating species.
- Assessed bacterial metabolic activity within the colonic lumen.
Main Results:
- SIV infection caused modest changes in the GI tract microbiome but significant dysbiosis with antiretroviral administration.
- Bacterial DNA analysis revealed a preference for Proteobacteria translocation.
- Increased metabolic activity of Proteobacteria was observed in the colonic lumen of SIV-infected macaques.
Conclusions:
- Proteobacteria are preferentially translocated during SIV infection.
- Gut microbiome composition and metabolic activity alterations may offer therapeutic benefits for HIV patients.
- Findings provide insights into HIV disease progression and potential microbiome-targeted interventions.
Related Concept Videos
Colonisation of Pathogens
Bacterial Translocation and Protein Secretion
Inflammatory Bowel Disease III: Crohn's Disease
Bacterial Meningitis II: Pathophysiology
Intracellular Movement of Viruses and Bacteria
Development of Human Microbiota

